Rehabilitation Interventions in Head and Neck Cancer

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCHENG, Jessica T.
dc.contributor.authorEMOS, Marc Ramos
dc.contributor.authorLEITE, Victor
dc.contributor.authorCAPOZZI, Lauren
dc.contributor.authorWOODROW, Lindsey E.
dc.contributor.authorGUTIERREZ, Carolina
dc.contributor.authorNGO-HUANG, An
dc.contributor.authorKRAUSE, Kate J.
dc.contributor.authorPARKE, Sara C.
dc.contributor.authorLANGELIER, David Michael
dc.date.accessioned2024-04-05T19:36:27Z
dc.date.available2024-04-05T19:36:27Z
dc.date.issued2024
dc.description.abstractObjective: The aim of the study is to identify and appraise current evidence for rehabilitation interventions in head and neck cancer. Design: A previously published scoping review spanning 1990 through April 2017 was updated through January 11, 2023 and narrowed to include only interventional studies (Arch Phys Med Rehabil. 2019;100(12):2381-2388). Included studies had a majority head and neck cancer population and rehabilitation-specific interventions. Pairs of authors extracted data and evaluated study quality using the PEDro tool. Results were organized by intervention type. Results: Of 1338 unique citations, 83 studies with 87 citations met inclusion criteria. The median study sample size was 49 (range = 9-399). The most common interventions focused on swallow (16 studies), jaw (11), or both (6), followed by whole-body exercise (14) and voice (10). Most interventions took place in the outpatient setting (77) and were restorative in intent (65 articles). The overall study quality was fair (median PEDro score 5, range 0-8); none were of excellent quality (PEDro >9). Conclusions: Most head and neck cancer rehabilitation interventions have focused on restorative swallow and jaw exercises and whole-body exercise to address dysphagia, trismus, and deconditioning. More high-quality evidence for head and neck cancer rehabilitation interventions that address a wider range of impairments and activity and social participation limitations during various cancer care phases is urgently needed to reduce head and neck cancer-associated morbidity.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexScopus
dc.description.indexDimensions
dc.description.indexWoS
dc.identifier.citationAMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, v.103, n.3S, suppl.1, p.S62-S71, 2024
dc.identifier.doi10.1097/PHM.0000000000002384
dc.identifier.eissn1537-7385
dc.identifier.issn0894-9115
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/59096
dc.language.isoeng
dc.publisherLIPPINCOTT WILLIAMS & WILKINSeng
dc.relation.ispartofAmerican Journal of Physical Medicine & Rehabilitation
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright LIPPINCOTT WILLIAMS & WILKINSeng
dc.subjectHead and Neck Neoplasmseng
dc.subjectRehabilitationeng
dc.subjectTrismuseng
dc.subjectDeglutition Disorderseng
dc.subject.otherquality-of-lifeeng
dc.subject.otherrandomized controlled-trialeng
dc.subject.otherprophylactic swallowing exerciseseng
dc.subject.otheraccessory nerve injuryeng
dc.subject.otherelectrical-stimulationeng
dc.subject.othervoice rehabilitationeng
dc.subject.otherlaryngeal-cancereng
dc.subject.otherresistance exerciseeng
dc.subject.otherradiation-therapyeng
dc.subject.otherpsychosocial interventioneng
dc.subject.wosRehabilitationeng
dc.subject.wosSport Scienceseng
dc.titleRehabilitation Interventions in Head and Neck Cancereng
dc.typearticleeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryCanadá
hcfmusp.affiliation.countryisous
hcfmusp.affiliation.countryisoca
hcfmusp.author.externalCHENG, Jessica T.:City Hope Orange Cty Lennar Fdn Canc Ctr, Dept Support Care Med, Irvine, CA 92618 USA
hcfmusp.author.externalEMOS, Marc Ramos:SUNY Downstate Hlth Sci Univ, Dept Orthoped Surg & Rehabil, Brooklyn, NY USA
hcfmusp.author.externalCAPOZZI, Lauren:Univ Calgary, Fac Kinesiol, Calgary, AB, Canada; Cumming Sch Med, Dept Clin Neurosci, Div Phys Med & Rehabil, Calgary, AB, Canada
hcfmusp.author.externalWOODROW, Lindsey E.:Univ Manitoba, Dept Internal Med, Sect Phys Med & Rehabil, Winnipeg, MB, Canada
hcfmusp.author.externalGUTIERREZ, Carolina:UTHlth Houston, McGovern Med Sch, Dept Phys Med & Rehabil, Houston, TX USA
hcfmusp.author.externalNGO-HUANG, An:Univ Texas MD Anderson Canc Ctr, Dept Palliat Rehabil & Integrat Med, Houston, TX USA
hcfmusp.author.externalKRAUSE, Kate J.:Univ Texas MD Anderson Canc Ctr, Res Med Lib, Houston, TX 77030 USA
hcfmusp.author.externalPARKE, Sara C.:Mayo Clin Arizona, Dept Phys Med & Rehabil, Phoenix, AZ USA
hcfmusp.author.externalLANGELIER, David Michael:Univ Hlth Network, Dept Med, Div Phys Med & Rehabil, Toronto, ON, Canada; Univ Toronto, Toronto, ON, Canada
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcVICTOR FIGUEIREDO LEITE
hcfmusp.description.beginpageS62
hcfmusp.description.endpageS71
hcfmusp.description.issue3S
hcfmusp.description.issuesuppl 1
hcfmusp.description.volume103
hcfmusp.origemWOS
hcfmusp.origem.dimensionspub.1168908596
hcfmusp.origem.pubmed38364033
hcfmusp.origem.scopus2-s2.0-85185392749
hcfmusp.origem.wosWOS:001163572000005
hcfmusp.publisher.cityPHILADELPHIAeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAghili M, 2007, EUR J ONCOL NURS, V11, P179, DOI 10.1016/j.ejon.2006.03.005eng
hcfmusp.relation.referenceAhlberg A, 2011, ACTA OTO-LARYNGOL, V131, P552, DOI 10.3109/00016489.2010.532157eng
hcfmusp.relation.referenceAngadi V., 2020, J Voice, V34, p962.eng
hcfmusp.relation.reference[Anonymous], 2020, J PHYSIOTHER, V66, P59, DOI 10.1016/j.jphys.2019.08.005eng
hcfmusp.relation.referenceAtar S, 2023, PHYSIOTHER THEOR PR, V39, P1832, DOI 10.1080/09593985.2022.2056862eng
hcfmusp.relation.referenceBadr H, 2019, CANCER-AM CANCER SOC, V125, P1176, DOI 10.1002/cncr.31906eng
hcfmusp.relation.referenceBalbinot J, 2022, BRAZ J OTORHINOLAR, V88, P491, DOI 10.1016/j.bjorl.2020.10.005eng
hcfmusp.relation.referenceBergström L, 2017, SUPPORT CARE CANCER, V25, P2683, DOI 10.1007/s00520-017-3676-xeng
hcfmusp.relation.referenceBorras JM, 2015, RADIOTHER ONCOL, V116, P45, DOI 10.1016/j.radonc.2015.04.021eng
hcfmusp.relation.referenceBressan V, 2017, SUPPORT CARE CANCER, V25, P1699, DOI 10.1007/s00520-017-3618-7eng
hcfmusp.relation.referenceBUCHBINDER D, 1993, J ORAL MAXIL SURG, V51, P863, DOI 10.1016/S0278-2391(10)80104-1eng
hcfmusp.relation.referenceCampbell KL, 2019, MED SCI SPORT EXER, V51, P2375, DOI 10.1249/MSS.0000000000002116eng
hcfmusp.relation.referenceCapozzi LC, 2016, CANCER-AM CANCER SOC, V122, P1185, DOI 10.1002/cncr.29863eng
hcfmusp.relation.referenceCarnaby-Mann G, 2012, INT J RADIAT ONCOL, V83, P210, DOI 10.1016/j.ijrobp.2011.06.1954eng
hcfmusp.relation.referenceChen YH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237133eng
hcfmusp.relation.referencede Morton NA, 2009, AUST J PHYSIOTHER, V55, P129, DOI 10.1016/S0004-9514(09)70043-1eng
hcfmusp.relation.referenceDenk DM, 1997, ORL J OTO-RHINO-LARY, V59, P100, DOI 10.1159/000276918eng
hcfmusp.relation.referenceDIETZ JH, 1969, MED CLIN N AM, V53, P607eng
hcfmusp.relation.referenceDo JH, 2018, ORAL ONCOL, V86, P100, DOI 10.1016/j.oraloncology.2018.06.019eng
hcfmusp.relation.referenceDu E, 2019, LARYNGOSCOPE, V129, P2506, DOI 10.1002/lary.27807eng
hcfmusp.relation.referenceFong SSM, 2014, J CANCER SURVIV, V8, P618, DOI 10.1007/s11764-014-0372-4eng
hcfmusp.relation.referenceFong SSM, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/495274eng
hcfmusp.relation.referenceGarcia MK, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.16910eng
hcfmusp.relation.referenceGkaintatzi E, 2022, CURR ONCOL, V29, P9305, DOI 10.3390/curroncol29120729eng
hcfmusp.relation.referenceGormley M, 2022, BRIT DENT J, V233, P780, DOI 10.1038/s41415-022-5166-xeng
hcfmusp.relation.referenceGrandi Gisela, 2007, Med Oral Patol Oral Cir Bucal, V12, pE105eng
hcfmusp.relation.referenceGrote M, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1157-0eng
hcfmusp.relation.referenceHajdú SF, 2021, DYSPHAGIA, DOI 10.1007/s00455-021-10320-5eng
hcfmusp.relation.referenceHammerlid E, 1999, OTOLARYNG HEAD NECK, V120, P507eng
hcfmusp.relation.referenceHogdal N, 2015, ACTA ONCOL, V54, P80, DOI 10.3109/0284186X.2014.954677eng
hcfmusp.relation.referenceHolm LV, 2012, SUPPORT CARE CANCER, V20, P2913, DOI 10.1007/s00520-012-1420-0eng
hcfmusp.relation.referenceHsiang CC, 2019, ENT-EAR NOSE THROAT, V98, pE73, DOI 10.1177/0145561319839822eng
hcfmusp.relation.referenceKangas M, 2013, PSYCHO-ONCOLOGY, V22, P1665, DOI 10.1002/pon.3208eng
hcfmusp.relation.referenceKarlsson T, 2022, ACTA ONCOL, V61, P349, DOI 10.1080/0284186X.2021.1995891eng
hcfmusp.relation.referenceKarlsson T, 2017, LOGOP PHONIATR VOCO, V42, P167, DOI 10.1080/14015439.2016.1250943eng
hcfmusp.relation.referenceKotz T, 2012, ARCH OTOLARYNGOL, V138, P376, DOI 10.1001/archoto.2012.187eng
hcfmusp.relation.referenceKrisciunas GP, 2017, DYSPHAGIA, V32, P327, DOI 10.1007/s00455-016-9760-4eng
hcfmusp.relation.referenceKwon DI, 2022, J LARYNGOL OTOL, V136, P433, DOI 10.1017/S0022215121003212eng
hcfmusp.relation.referenceLangmore SE, 2016, HEAD NECK-J SCI SPEC, V38, pE1221, DOI 10.1002/hed.24197eng
hcfmusp.relation.referenceLauchlan DT, 2011, EUR J CANCER CARE, V20, P113, DOI 10.1111/j.1365-2354.2009.01149.xeng
hcfmusp.relation.referenceLaw T, 2017, LARYNGOSCOPE, V127, P1119, DOI 10.1002/lary.26243eng
hcfmusp.relation.referenceLazarus CL, 2014, INT J ORAL MAX SURG, V43, P523, DOI 10.1016/j.ijom.2013.10.023eng
hcfmusp.relation.referenceLee JE, 2019, CANCER NURS, V42, P218, DOI 10.1097/NCC.0000000000000594eng
hcfmusp.relation.referenceLee R, 2018, BRIT J ORAL MAX SURG, V56, P283, DOI 10.1016/j.bjoms.2018.02.012eng
hcfmusp.relation.referenceLi YH, 2019, CLIN ORAL INVEST, V23, P469, DOI 10.1007/s00784-018-2456-4eng
hcfmusp.relation.referenceLin KY, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18031291eng
hcfmusp.relation.referenceLin PH, 2011, SUPPORT CARE CANCER, V19, P91, DOI 10.1007/s00520-009-0792-2eng
hcfmusp.relation.referenceLonbro S, 2013, RADIOTHER ONCOL, V108, P314, DOI 10.1016/j.radonc.2013.07.002eng
hcfmusp.relation.referenceLonbro S, 2013, ACTA ONCOL, V52, P310, DOI 10.3109/0284186X.2012.741325eng
hcfmusp.relation.referenceLong YB, 2013, DISABIL REHABIL, V35, P450, DOI 10.3109/09638288.2012.697250eng
hcfmusp.relation.referenceLongobardi Y, 2020, EUR ARCH OTO-RHINO-L, V277, P2095, DOI 10.1007/s00405-020-05918-8eng
hcfmusp.relation.referenceLongobardi Y, 2019, SUPPORT CARE CANCER, V27, P3537, DOI 10.1007/s00520-019-4647-1eng
hcfmusp.relation.referenceLoorents V, 2014, ACTA ONCOL, V53, P530, DOI 10.3109/0284186X.2014.892211eng
hcfmusp.relation.referenceMachtay M, 2008, J CLIN ONCOL, V26, P3582, DOI 10.1200/JCO.2007.14.8841eng
hcfmusp.relation.referenceManier KK, 2018, NEURO-ONCOL PRACT, V5, P204, DOI 10.1093/nop/npy018eng
hcfmusp.relation.referenceMashhour Karim, 2018, Asian Pac J Cancer Prev, V19, P797eng
hcfmusp.relation.referenceMcEwen S, 2016, SUPPORT CARE CANCER, V24, P1449, DOI 10.1007/s00520-015-3021-1eng
hcfmusp.relation.referenceMcGarvey AC, 2015, HEAD NECK-J SCI SPEC, V37, P1022, DOI 10.1002/hed.23712eng
hcfmusp.relation.referenceMcLaughlin TM, 2020, LARYNGOSCOPE INVEST, V5, P879, DOI 10.1002/lio2.455eng
hcfmusp.relation.referenceMcNeely ML, 2008, CANCER, V113, P214, DOI 10.1002/cncr.23536eng
hcfmusp.relation.referenceMcNeely ML, 2015, PHYSIOTHER CAN, V67, P85, DOI 10.3138/ptc.2014-13Oeng
hcfmusp.relation.referenceMcNeely ML, 2004, HEAD NECK-J SCI SPEC, V26, P518, DOI 10.1002/hed.20010eng
hcfmusp.relation.referenceMedicine USNLo, 2021, Glossary of common site termseng
hcfmusp.relation.referenceMessing BP, 2017, DYSPHAGIA, V32, P487, DOI 10.1007/s00455-017-9790-6eng
hcfmusp.relation.referenceMichael CM, 2021, CANCER MED-US, V10, P4195, DOI 10.1002/cam4.4021eng
hcfmusp.relation.referenceMillgård M, 2020, J VOICE, V34, DOI 10.1016/j.jvoice.2018.09.011eng
hcfmusp.relation.referenceMortensen HR, 2015, DYSPHAGIA, V30, P304, DOI 10.1007/s00455-015-9600-yeng
hcfmusp.relation.referenceNational Comprehensive Cancer Network, HEAD NECK CANC VERSeng
hcfmusp.relation.referenceOsazuwa-Peters N, 2018, CANCER-AM CANCER SOC, V124, P4072, DOI 10.1002/cncr.31675eng
hcfmusp.relation.referenceOzdemir K, 2021, LARYNGOSCOPE, V131, pE1550, DOI 10.1002/lary.29205eng
hcfmusp.relation.referencePaim ÉD, 2019, J ORAL REHABIL, V46, P1142, DOI 10.1111/joor.12851eng
hcfmusp.relation.referenceParke SC, 2022, CURR ONCOL REP, V24, P517, DOI 10.1007/s11912-022-01227-xeng
hcfmusp.relation.referenceParke SC, 2019, ARCH PHYS MED REHAB, V100, P2381, DOI 10.1016/j.apmr.2019.03.022eng
hcfmusp.relation.referencePauli N, 2015, HEAD NECK-J SCI SPEC, V37, P1738, DOI 10.1002/hed.23818eng
hcfmusp.relation.referencePergolotti M, 2015, J GERIATR ONCOL, V6, P194, DOI 10.1016/j.jgo.2015.01.004eng
hcfmusp.relation.referencePfister DG, 2010, J CLIN ONCOL, V28, P2565, DOI 10.1200/JCO.2009.26.9860eng
hcfmusp.relation.referenceQin F, 2022, ACTA MEDICA MEDITERR, V38, P971, DOI 10.19193/0393-6384_2022_2_149eng
hcfmusp.relation.referenceQualizza M, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.12939eng
hcfmusp.relation.referenceRidner SH, 2021, SUPPORT CARE CANCER, V29, P795, DOI 10.1007/s00520-020-05540-8eng
hcfmusp.relation.referenceRingash J, 2018, SEMIN RADIAT ONCOL, V28, P64, DOI 10.1016/j.semradonc.2017.08.008eng
hcfmusp.relation.referenceRodriguez AM, 2019, DISABIL REHABIL, V41, P2093, DOI 10.1080/09638288.2018.1459880eng
hcfmusp.relation.referenceRogers LQ, 2013, HEAD NECK-J SCI SPEC, V35, P1178, DOI 10.1002/hed.23118eng
hcfmusp.relation.referenceRyu JS, 2009, ORAL ONCOL, V45, P665, DOI 10.1016/j.oraloncology.2008.10.005eng
hcfmusp.relation.referenceSahin M, 2016, DIS ESOPHAGUS, V29, P41, DOI 10.1111/dote.12297eng
hcfmusp.relation.referenceSamuel SR, 2013, INDIAN J MED RES, V137, P515eng
hcfmusp.relation.referenceSamuel SR, 2019, SUPPORT CARE CANCER, V27, P3913, DOI 10.1007/s00520-019-04750-zeng
hcfmusp.relation.referenceSandler ML, 2019, HEAD NECK-J SCI SPEC, V41, P3806, DOI 10.1002/hed.25908eng
hcfmusp.relation.referenceSemple CJ, 2009, SUPPORT CARE CANCER, V17, P379, DOI 10.1007/s00520-008-0480-7eng
hcfmusp.relation.referenceShimada Y, 2007, ACTA OTO-LARYNGOL, V127, P491, DOI 10.1080/00016480600895151eng
hcfmusp.relation.referenceSilver JK, 2013, CA-CANCER J CLIN, V63, P295, DOI 10.3322/caac.21186eng
hcfmusp.relation.referenceSlovarp LJ., 2015, Contrasting Two Prophylactic Dysphagia Interventions for Patients with Head and Neck Cancer Treated with Radiotherpy with or without Adjunctive Chemotherapyeng
hcfmusp.relation.referenceSu TL, 2017, ORAL ONCOL, V74, P130, DOI 10.1016/j.oraloncology.2017.10.002eng
hcfmusp.relation.referenceTang Y, 2011, STRAHLENTHER ONKOL, V187, P39, DOI 10.1007/s00066-010-2151-0eng
hcfmusp.relation.referenceTaylor JC, 2004, ARCH OTOLARYNGOL, V130, P764, DOI 10.1001/archotol.130.6.764eng
hcfmusp.relation.referenceTsai KY, 2022, MEDICINE, V101, DOI 10.1097/MD.0000000000030910eng
hcfmusp.relation.referenceTuomi L, 2022, HEAD NECK-J SCI SPEC, V44, P862, DOI 10.1002/hed.26982eng
hcfmusp.relation.referenceTuomi L, 2014, INT J RADIAT ONCOL, V89, P964, DOI 10.1016/j.ijrobp.2014.04.030eng
hcfmusp.relation.referenceTuomi L, 2014, J VOICE, V28, P62, DOI 10.1016/j.jvoice.2013.02.008eng
hcfmusp.relation.referenceVakharia KT, 2007, OTOLARYNG HEAD NECK, V136, P405, DOI 10.1016/j.otohns.2006.10.018eng
hcfmusp.relation.referenceVan den Hoogen FJA, 1998, CLIN OTOLARYNGOL, V23, P425, DOI 10.1046/j.1365-2273.1998.00164.xeng
hcfmusp.relation.referencevan der Geer SJ, 2020, SUPPORT CARE CANCER, V28, P9, DOI 10.1007/s00520-019-05075-7eng
hcfmusp.relation.referencevan der Molen L, 2014, EUR ARCH OTO-RHINO-L, V271, P1257, DOI 10.1007/s00405-013-2640-8eng
hcfmusp.relation.referencevan der Molen L, 2011, DYSPHAGIA, V26, P155, DOI 10.1007/s00455-010-9288-yeng
hcfmusp.relation.referencevan Gogh CDL, 2006, CANCER-AM CANCER SOC, V106, P95, DOI 10.1002/cncr.21578eng
hcfmusp.relation.referencevan Rooijen S, 2019, BMC CANCER, V19, DOI 10.1186/s12885-018-5232-6eng
hcfmusp.relation.referenceWen LY, 2023, SUPPORT CARE CANCER, V31, DOI 10.1007/s00520-022-07548-8eng
hcfmusp.relation.referenceWHO, 2023, International classification of functioning, disability, and health (ICF)eng
hcfmusp.relation.referenceWong Raimond K, 2010, J Soc Integr Oncol, V8, P35eng
hcfmusp.relation.referenceWu PX, 2018, EUR ARCH OTO-RHINO-L, V275, P795, DOI 10.1007/s00405-018-4875-xeng
hcfmusp.relation.referenceXiao CH, 2013, ORAL ONCOL, V49, P360, DOI 10.1016/j.oraloncology.2012.10.004eng
hcfmusp.relation.referenceYen CJ, 2019, SUPPORT CARE CANCER, V27, P4687, DOI 10.1007/s00520-019-04786-1eng
hcfmusp.relation.referenceZatarain LA, 2018, INTEGR CANCER THER, V17, P960, DOI 10.1177/1534735418784363eng
hcfmusp.relation.referenceZhang J, 2022, ORAL ONCOL, V134, DOI 10.1016/j.oraloncology.2022.106097eng
hcfmusp.relation.referenceZhao SG, 2016, HEAD NECK-J SCI SPEC, V38, pE1086, DOI 10.1002/hed.24162eng
hcfmusp.relation.referenceZimmermann T, 2005, BIOL TRACE ELEM RES, V106, P193, DOI 10.1385/BTER:106:3:193eng
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublication3ae9a70a-e8d1-414e-a556-c24274ad22c3
relation.isAuthorOfPublication.latestForDiscovery3ae9a70a-e8d1-414e-a556-c24274ad22c3
Arquivos